MedTrace Logo

SpermQT Prospective Observational Trial

NCT05966883 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-03-12

No results posted yet for this study

Summary

The goal of the study is to validate the ability of the Epigenetic Sperm Quality Test (SpermQT) to assess a man's sperm quality and corresponding success of infertility treatments.

Conditions

  • Male Infertility

Sponsors & Collaborators

  • Yale University

    collaborator OTHER

  • Boston IVF

    collaborator OTHER

  • Shady Grove Fertility

    collaborator UNKNOWN

  • University of Washington

    collaborator OTHER

  • Brigham Young University

    collaborator OTHER

  • Male Fertility and Sexual Medicine Specialists

    collaborator UNKNOWN

  • Inception Fertility Research Institute, LLC

    collaborator INDUSTRY

  • Inherent Biosciences

    lead INDUSTRY

Principal Investigators

  • Kristin Brogaard, PhD · Inherent Biosciences

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2026-04-15
Completion
2026-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05966883 on ClinicalTrials.gov